Company registration number 08898793 (England and Wales)
UK ONCOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
UK ONCOLOGY LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 10
UK ONCOLOGY LIMITED
COMPANY INFORMATION
- 1 -
Director
Dr Gregory Wilson
Company number
08898793
Registered office
8 Darley Avenue
West Didsbury
Manchester
M20 2XF
Accountants
Xeinadin
Riverside House
Kings Reach Business Park
Yew Street
Stockport
SK4 2HD
UK ONCOLOGY LIMITED
BALANCE SHEET
AS AT 28 AUGUST 2025
28 August 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
6
26,508
32,006
Investment property
7
538,000
503,000
564,508
535,006
Current assets
Debtors
8
74,621
41,969
Investments
9
3,057,321
1,785,706
Cash at bank and in hand
728,030
1,109,554
3,859,972
2,937,229
Creditors: amounts falling due within one year
10
(136,379)
(35,462)
Net current assets
3,723,593
2,901,767
Total assets less current liabilities
4,288,101
3,436,773
Provisions for liabilities
(197,273)
(132,332)
Net assets
4,090,828
3,304,441
Capital and reserves
Called up share capital
11
100
100
Revaluation reserve
571,941
372,993
Profit and loss reserves
3,518,787
2,931,348
Total equity
4,090,828
3,304,441
UK ONCOLOGY LIMITED
BALANCE SHEET (CONTINUED)
AS AT 28 AUGUST 2025
28 August 2025
- 3 -

For the financial year ended 28 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 10 February 2026
Dr Gregory Wilson
Director
Company registration number 08898793 (England and Wales)
UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 AUGUST 2025
- 4 -
1
Accounting policies
Company information

UK Oncology Limited is a private company limited by shares incorporated in England and Wales. The registered office is 8 Darley Avenue, West Didsbury, Manchester, M20 2XF.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover comprises the fair value of the consideration received or receivable for provision of services in the

ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates

and discounts.

The company recognises revenue when:

The amount of revenue can be reliably measured;

it is probable that future economic benefits will flow to the entity;

and specific criteria have been met for each of the company's activities.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of an entity represents the excess of the cost of

acquisition over the company's interest in the net fair value of identifiable assets, liabilities and contingent

liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost

and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life,

which is 10 years.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% Reducing balance
Motor vehicles
25% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 AUGUST 2025
1
Accounting policies
(Continued)
- 5 -
1.6
Investment property

Investment property comprises of property and interests in land held either to earn rental income or for capital

appreciation, or both. Investment properties are initially measured at cost, including related transaction costs.

Borrowing costs associated with direct expenditure on investment properties under development are

capitalised. Interest is capitalised as from the commencement of the development work until the date of

practical completion or, if earlier, the date that outgoings exceeded income. After initial recognition, investment

properties are carried at their fair values based on market value as determined at each reporting date. The

difference between the fair value of investment property at the reporting date and it's carrying amount prior to

re-measurement is included in the income statement as valuation surplus or deficit. Profit on disposal is

determined as the difference between the sales proceeds and the carrying amount of the asset at the

commencement of the accounting period plus capital expenditure in the period.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 AUGUST 2025
1
Accounting policies
(Continued)
- 6 -
1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 AUGUST 2025
1
Accounting policies
(Continued)
- 7 -
1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying

amount of assets and liabilities are as follows.

Revaluation of investment property

Investment property is carried at fair value, with changes in fair value being recognised in the statement of

income and retained earnings. The valuation of investment property is inherently subjective due to, among

other factors, the individual nature of the property, its location and the expected future rental revenues from

that particular property. As a result, the valuation the company places on its property portfolio is subject to a

degree of uncertainty and are made on the basis of assumptions which may not prove to be accurate,

particularly in period of volatility or low transaction flow in the property market.

3
Operating profit
2025
2024
Operating profit for the year is stated after charging:
£
£
Depreciation of owned tangible fixed assets
8,947
11,132
4
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 AUGUST 2025
- 8 -
5
Intangible fixed assets
Goodwill
£
Cost
At 29 August 2024 and 28 August 2025
15,000
Amortisation and impairment
At 29 August 2024 and 28 August 2025
15,000
Carrying amount
At 28 August 2025
-
0
At 28 August 2024
-
0
6
Tangible fixed assets
Computers
Motor vehicles
Total
£
£
£
Cost
At 29 August 2024
18,225
63,879
82,104
Additions
3,449
-
0
3,449
At 28 August 2025
21,674
63,879
85,553
Depreciation and impairment
At 29 August 2024
13,665
36,433
50,098
Depreciation charged in the year
2,086
6,861
8,947
At 28 August 2025
15,751
43,294
59,045
Carrying amount
At 28 August 2025
5,923
20,585
26,508
At 28 August 2024
4,560
27,446
32,006
7
Investment property
2025
£
Fair value
At 29 August 2024
503,000
Revaluations
35,000
At 28 August 2025
538,000
UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 AUGUST 2025
7
Investment property
(Continued)
- 9 -

Investment properties are properties held to earn rentals and/or for capital appreciation. Investment properties

are initially measured at cost, including transaction costs.

Subsequently investment properties are measured at fair value. Investment property valuations are based on

an open market value. Deferred tax is provided on these movements. Gains and losses arising from changes

in the fair value of investment properties are included within the statement of income and retained earnings in

the period in which they arise.

There has been no valuation of investment properties by an independent valuer.

8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
26,920
35,264
Other debtors
47,701
6,705
74,621
41,969
9
Current asset investments
2025
2024
£
£
Other investments
3,057,321
1,785,706

Investments with a net book value of £2,921,165 (2024: £1,649,550) are listed on a recognised stock exchange and had a market value of £2,921,165 (2024: £1,649,550) at the financial year end.

10
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
114,655
22,712
Other creditors
21,724
12,750
136,379
35,462
11
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
UK ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 AUGUST 2025
- 10 -
12
Related party transactions

During the year the director advanced monies to the company on an interest free basis, the amount owing to

the director at the year end date was £1,587 (2024: £312). This amount is interest free and repayable on

demand.

13
Control

The company is controlled by the director by virtue of his 100% shareholding.

2025-08-28 2024-08-29 false false false 10 February 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr Gregory Wilson 08898793 2024-08-29 2025-08-28 08898793 2025-08-28 08898793 bus:Director1 2024-08-29 2025-08-28 08898793 bus:RegisteredOffice 2024-08-29 2025-08-28 08898793 2024-08-28 08898793 core:ComputerEquipment 2025-08-28 08898793 core:MotorVehicles 2025-08-28 08898793 core:ComputerEquipment 2024-08-28 08898793 core:MotorVehicles 2024-08-28 08898793 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-28 08898793 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-28 08898793 core:WithinOneYear 2025-08-28 08898793 core:WithinOneYear 2024-08-28 08898793 core:CurrentFinancialInstruments 2025-08-28 08898793 core:CurrentFinancialInstruments 2024-08-28 08898793 core:ShareCapital 2025-08-28 08898793 core:ShareCapital 2024-08-28 08898793 core:RevaluationReserve 2025-08-28 08898793 core:RevaluationReserve 2024-08-28 08898793 core:RetainedEarningsAccumulatedLosses 2025-08-28 08898793 core:RetainedEarningsAccumulatedLosses 2024-08-28 08898793 core:ShareCapitalOrdinaryShareClass1 2025-08-28 08898793 core:ShareCapitalOrdinaryShareClass1 2024-08-28 08898793 core:Goodwill 2024-08-29 2025-08-28 08898793 core:ComputerEquipment 2024-08-29 2025-08-28 08898793 core:MotorVehicles 2024-08-29 2025-08-28 08898793 2023-08-29 2024-08-28 08898793 core:NetGoodwill 2024-08-28 08898793 core:NetGoodwill 2025-08-28 08898793 core:NetGoodwill 2024-08-28 08898793 core:ComputerEquipment 2024-08-28 08898793 core:MotorVehicles 2024-08-28 08898793 2024-08-28 08898793 bus:OrdinaryShareClass1 2024-08-29 2025-08-28 08898793 bus:OrdinaryShareClass1 2025-08-28 08898793 bus:OrdinaryShareClass1 2024-08-28 08898793 bus:PrivateLimitedCompanyLtd 2024-08-29 2025-08-28 08898793 bus:SmallCompaniesRegimeForAccounts 2024-08-29 2025-08-28 08898793 bus:FRS102 2024-08-29 2025-08-28 08898793 bus:AuditExemptWithAccountantsReport 2024-08-29 2025-08-28 08898793 bus:FullAccounts 2024-08-29 2025-08-28 xbrli:pure xbrli:shares iso4217:GBP